AAAAAA
Results:
1-12
|
Results: 12
Authors:
Thompson, IM
Tangen, CM
Tolcher, A
Crawford, ED
Eisenberger, M
Moinpour, CM
Citation: Im. Thompson et al., Association of African-American ethnic background with survival in men with metastatic prostate cancer, J NAT CANC, 93(3), 2001, pp. 219-225
Authors:
Thompson, IM
Tangen, CM
Tolcher, A
Crawford, ED
Eisenberger, M
Moinpour, CM
Citation: Im. Thompson et al., Re: Association of African-American ethnic background with survival in menwith metastatic prostate cancer - Response, J NAT CANC, 93(15), 2001, pp. 1175-1175
Authors:
Busool, W
Eisenberger, M
Citation: W. Busool et M. Eisenberger, Exact static analysis of helicoidal structures of arbitrary shape and variable cross section, J STRUC ENG, 127(11), 2001, pp. 1266-1275
Authors:
Small, EJ
McMillan, A
Meyer, M
Chen, L
Slichenmyer, WJ
Lenehan, PF
Eisenberger, M
Citation: Ej. Small et al., Serum prostate-specific antigen decline as a marker of clinical outcome inhormone-refractory prostate cancer patients: Association with progression-free survival, pain end points, and survival, J CL ONCOL, 19(5), 2001, pp. 1304-1311
Authors:
Eisenberger, M
Efraim, E
Citation: M. Eisenberger et E. Efraim, In-plane vibrations of shear deformable curved beams, INT J NUM M, 52(11), 2001, pp. 1221-1234
Authors:
Jabareen, M
Eisenberger, M
Citation: M. Jabareen et M. Eisenberger, Free vibrations of non-homo geneous circular and annular membranes, J SOUND VIB, 240(3), 2001, pp. 409-429
Authors:
Small, EJ
Meyer, M
Marshall, ME
Reyno, LM
Meyers, FJ
Natale, RB
Lenehan, PF
Chen, L
Slichenmyer, WJ
Eisenberger, M
Citation: Ej. Small et al., Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: Results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone, J CL ONCOL, 18(7), 2000, pp. 1440-1450
Authors:
Moinpour, CM
Troxel, A
Lovato, LC
Eisenberger, M
Blumenstein, BA
Crawford, ED
Citation: Cm. Moinpour et al., Quality of life in advanced prostate cancer: Results of a randomized therapeutic trial - Response, J NAT CANC, 91(7), 1999, pp. 646-646
Authors:
Moinpour, CM
Troxel, A
Lovato, LC
Eisenberger, M
Blumenstein, BA
Crawford, ED
Citation: Cm. Moinpour et al., Quality of life in advanced prostate cancer: Results of a randomized therapeutic trial - Response, J NAT CANC, 91(4), 1999, pp. 381-382
Authors:
Levy, E
Eisenberger, M
Citation: E. Levy et M. Eisenberger, Dynamic analysis of trusses including the effect of local modes, STRUC ENG M, 7(1), 1999, pp. 81-94
Authors:
Bubley, GJ
Carducci, M
Dahut, W
Dawson, N
Daliani, D
Eisenberger, M
Figg, WD
Freidlin, B
Halabi, S
Hudes, G
Hussain, M
Kaplan, R
Myers, C
Oh, W
Petrylak, DP
Reed, E
Roth, B
Sartor, O
Scher, H
Simons, J
Sinibaldi, V
Small, EJ
Smith, MR
Trump, DL
Vollmer, R
Wilding, G
Citation: Gj. Bubley et al., Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the prostate-specific antigen working group, J CL ONCOL, 17(11), 1999, pp. 3461-3467
Authors:
Sinibaldi, VJW
Carducci, M
Laufer, M
Eisenberger, M
Citation: Vjw. Sinibaldi et al., Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer, SEMIN ONCOL, 26(5), 1999, pp. 45-48
Risultati:
1-12
|